INTRODUCING IPS: A PROGNOSTIC BIOMARKER FOR PATIENTS ON ICI THERAPY /// LEARN MORE INTRODUCING IPS: A PROGNOSTIC BIOMARKER FOR PATIENTS ON ICI THERAPY /// LEARN MORE
September 4 — 6, 2024 BOSTON, MA

Exhibit Booth #4
Plenary Session

World Clinical Biomarkers & CDx Summit 2024

Tempus is advancing precision medicine through the practical application of artificial intelligence in healthcare. We are pleased to attend the 14th annual World CB & CDx Summit and present how Tempus can support strategic CDx development through to commercialization.

Schedule a meeting with us
Plenary Session
September 4, 2024
live session
Time
3:10pm-3:40pm ET
Location
The Westin Boston Seaport District
425 Summer Street
Boston, MA 02210

Presenter
Alain Silk
Sr. Director, Regulatory Affairs (Tempus)

The Next Frontier in Diagnostics: From Regulatory Shifts to Novel Biomarkers

Explore the latest in diagnostic development as we delve into evolving regulatory landscapes and pre-market pathways. Learn how novel biomarkers and AI-driven algorithms are shaping the future of Companion Diagnostics (CDx). Gain insights into innovative strategies to regulatory challenges and how industry leaders are advancing precision medicine through cutting-edge approaches.

Read more

Schedule a meeting with us

We'll be in touch shortly.